Back to search

Article

Fibroblast Growth factor 23 and α-Klotho protein are associated with adverse clinical outcomes in non dialysis chronic kidney disease stage 1-5 patients

2019-07-02

Abstract excerpt

<h4>Background: </h4> Fibroblast Growth Factor 23 (FGF-23) and α-Klotho contribute to the patho-genesis of chronic kidney disease - mineral and bone disorders (CKD-MBD). The aim of our study was to evaluate the association of FGF-23 and α-Klotho levels with CKD-MBD parameters, as well as with renal prognosis and mortality, in CKD patients stage 1-5, not in renal replacement therapy (RRT). <h4>Methods:</h4> 128 pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9c73ad37-eddb-5429-a540-5dd0743dcc7e
DOI
10.21203/rs.2.10867/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fibroblast Growth factor 23 and α-Klotho protein are associated with adverse clinical outcomes in non dialysis chronic kidney disease stage 1-5 patientsDOI 10.21203/rs.2.10867/v1
Select a neighboring publication to make it the new centre.